Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with COVID-19 [in accordance with the diagnostic criteria of the Notice on Printing and Distributing COVID-19 Diagnosis and Treatment Plan (Trial Implementation Version 6th) issued by the National Health and Medical Commission], and meets the discharge criterion; 2. Aged 18 to 75 years old; 3. Be consious; 4. Volunteer to participate in the study and sign the informed consent form, and be able to understand, receive rehabilitation guidance and implement it.
Exclusion criteria
Exclusion criteria: 1. Patients diagnosed with the critical type of COVID-19 [in accordance with the diagnostic criteria of the Notice on Printing and Distributing COVID-19 Diagnosis and Treatment Plan (Trial Implementation Version 6th) issued by the National Health and Medical Commission], and with unstable vital signs; 2. Patients with severe primary disease of liver, kidney, hematological and endocrine system; 3. Pregnant or lactating women; 4. Patients with a history of psychosis, substance abuse or dependence; 5. Those who participate in other clinical trials within 3 months when screening; 6. Patients with other diseases being treated with medications and affecting the study observation; 7. Other patients that considered unsuitable for the clinical trial by the investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximal inspiratory pressure;Respiratory muscle evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Dyspnea evaluation;6-Minute Walking Test;Activity of Daily Living;Evluation of International Classification of Functioning, Disability and Health;Hamilton Anxiety Scale;Hamilton Depression Scale;Quality of Life; | — |
Countries
China
Contacts
The First Affiliated Hospital of Nanchang University